A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis

Clinical trial NCT04274257 · COMPLETED

Trial details

NCT number: NCT04274257
Sponsor: Tokyo University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Scleroderma, Systemic Skin Sclerosis Lung Fibrosis Autoimmune Diseases Collagen Diseases

Start date: 2017-12-04
Primary completion: 2019-05-09
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.